National Institutes of Health
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Phase 2 is a funding opportunity from National Institutes of Health, up to $1.0M, closing June 8, 2027.
Overview
NIDA seeks to further advance its mission in the area of single cell biology. Since 2020, the NIDA-funded Single Cell Opioid Responses in the Context of HIV (SCORCH) consortium has generated single-nucleus datasets from human and animal postmortem brain tissue under conditions of HIV infection, antiretroviral…